next-generation sequencing

Open Access
TMPRSS2:ERG Gene Fusion Might Predict Resistance to PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer
TIM SVENSTRUP POULSEN, ANDERS NYGAARD LØRUP, PER KONGSTED, RIKKE LØVENDAHL EEFSEN, MARTIN HØJGAARD and ESTRID VILMA HØGDALL

Anticancer Research October 2024, 44 (10) 4203-4211; DOI: https://doi.org/10.21873/anticanres.17250
You have access
Real-world Comparison of P53 Immunohistochemistry and TP53 Mutation Analysis Using Next-generation Sequencing
HYUNWOO LEE, YOON AH CHO, DEOK GEUN KIM, JAE YOUNG SON and EUN YOON CHO

Anticancer Research September 2024, 44 (9) 3983-3994; DOI: https://doi.org/10.21873/anticanres.17227
You have access
Incorporating Tumor Genomic Profiling and Circulating Tumor Cell-derived Organoids into Clinical Practice for Gastrointestinal Cancers
WEN-CHI WU, CHIEN-FU HSU, MING-HUANG CHEN, SAN-CHI CHEN, YI-PING HUNG and NAI-JUNG CHIANG

Anticancer Research August 2024, 44 (8) 3481-3491; DOI: https://doi.org/10.21873/anticanres.17168
You have access
Comparative Study on the Clinicopathologic and Molecular Characteristics of Primary and Secondary Diffuse Large B-cell Lymphoma in the Central Nervous System
JEONGEUN DO, LEONARD N. YENWONGFAI, SUNG-IM DO, SO-WOON KIM and KIYONG NA

Anticancer Research July 2024, 44 (7) 2953-2960; DOI: https://doi.org/10.21873/anticanres.17107
You have access
Upfront Multiplex Gene Test Helps Prolong Survival in Advanced Non-small Cell Lung Cancer
HIROKI KANASAKI, YUICHI OZAWA, NAOTO NAKAMURA, KIMIHIKO NAGASAKI, WATARU MATSUYAMA, DAISUKE AKAHORI, MITSURU NIWA, TAKASHI OGASAWARA and JUN SATO

Anticancer Research February 2024, 44 (2) 723-730; DOI: https://doi.org/10.21873/anticanres.16863
You have access
Multi-gene Liquid Biopsy to Detect Resistance to First-line Osimertinib in Patients With EGFR-mutated Lung Adenocarcinoma
SHIN ITO, KYOJI TSURUMI, NORIHISA SHINDO, SATOSHI SOMA, KAZUNORI YAMAGUCHI, KEIICHI TAMAI, MAI MOCHIZUKI, HARUNA FUJIMORI, MAMI MORITA, KANA WATANABE, AYA SUZUKI, TATSURO FUKUHARA and JUN YASUDA

Anticancer Research November 2023, 43 (11) 5031-5040; DOI: https://doi.org/10.21873/anticanres.16702
You have access
Impact of Genomic Alterations on the Clinical Outcome of Patients With Hepatitis B-related Hepatocellular Carcinoma Receiving Curative Surgery: A Retrospective Cohort Study
CHIH-CHI WANG, WEN-LANG FAN, TING-TING LIU, SEE-TONG PANG, JING-HOUNG WANG, CHAO-CHENG HUANG, ENG-YEN HUANG and YEN-HAO CHEN

Anticancer Research October 2023, 43 (10) 4709-4722; DOI: https://doi.org/10.21873/anticanres.16667
You have access
Pre-and Postoperative Circulating Tumour DNA in Patients With Gastrointestinal Stromal Tumour – A Methodological Assessment Study
CHARLOTTE MARGARETA BRINCH, NINNA AGGERHOLM-PEDERSEN, TIM SVENSTRUP POULSEN, WOJCIECH SKOVRIDER-RUMINSKI, PIETER DE HEER, LUIT PENNINGA, ANDERS KRARUP-HANSEN and ESTRID HOGDALL

Anticancer Research November 2022, 42 (11) 5527-5537; DOI: https://doi.org/10.21873/anticanres.16022
You have access
Oncogenic Fusions in Gliomas: An Institutional Experience
JIRI POLIVKA, MARIAN SVAJDLER, VLADIMIR PRIBAN, JAN MRACEK, PETR KASIK, PETR MARTINEK, NIKOLA PTAKOVA, MAHYAR SHARIF BAGHERI, DATTATRYA SHETTI, MARTIN PESTA, PAVEL POTUZNIK and ONDREJ TOPOLCAN

Anticancer Research April 2022, 42 (4) 1933-1939; DOI: https://doi.org/10.21873/anticanres.15671
You have access
External Validation of ALK and ROS1 Fusions Detected Using an Oncomine Comprehensive Assay
SO-WOON KIM, SUNG-IM DO and KIYONG NA

Anticancer Research September 2021, 41 (9) 4609-4617; DOI: https://doi.org/10.21873/anticanres.15274

Main menu

User menu

Search

next-generation sequencing

Pages